Thuja Capital
Jose Calle Gordo is a global medical device executive with over 30 years of business experience. Jose has had general management and functional responsibility in a broad spectrum of roles, including General/Executive Management, CEO and Board responsibilities as well as leadership roles in Research & Development, Clinical Research, Market Development and Sales & Marketing. Most recently, he served as CEO and director of BIOSENSORS International, where he build a multinational management team and lead the transformation and expansion of Biosensors from a start up to a recognized multi-national in Vascular Intervention. Prior to joining BIOSENSORS, he held several leadership roles at ABBOTT (Structural Heart & Vascular) and GUIDANT (Cardiac Rhythm Management, Vascular Intervention, Endovascular Solutions and Cardiac Surgery). Jose started his career at Eli Lilly where he had a number of commercial roles with growing responsibility in the field of cardiac devices. Jose Calle Gordo holds an electrical engineering degree (MSc) from the Universidad Politecnica de Madrid, Spain.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Thuja Capital
Thuja Capital is an early-stage venture capital firm located in Utrecht, The Netherlands. They invest in product-focused companies that aim to have a true impact on patients and doctors alike, as demonstrated in clinical studies to enable a health claim.